Business Context and Reporting Period
This Form 8-K is a Current Report filed by BioVie Inc. on May 17, 2021. The filing serves as a Regulation FD disclosure to announce the release of investor presentations and the company's participation in an upcoming conference.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on the dissemination of presentation materials rather than the reporting of financial results.
Material Changes
No material changes to financial performance or operations are reported in this document. The primary event is the commencement of a series of investor communications.
Guidance, Outlook, and Management Commentary
- Investor Presentations: Beginning May 17, 2021, the Company plans to distribute a "Corporate Presentation" (Exhibit 99.1) and an "R&D Day Presentation" (Exhibit 99.2).
- Conference Participation: The Company expects to utilize the Investor Presentation at the BRiley Conference starting May 19, 2021, and in future meetings with investors and analysts.
- Availability: Presentations are available on the Company's website under the "Events and Presentations" tab.
- Legal Disclaimer: The information in the presentations is summary in nature and is not deemed "filed" under the Exchange Act unless specifically incorporated by reference. The Company undertakes no obligation to update this information.
Key Facts for Investor Verification
- Verify the content of the attached Corporate Presentation (Exhibit 99.1) and R&D Day Presentation (Exhibit 99.2) for specific business updates.
- Confirm the date and details of the BRiley Conference presentation scheduled for May 19, 2021.
- Note that this filing does not contain audited financial data; refer to the most recent 10-K or 10-Q for financial metrics.